GB2172704B - Antigenically active protein and its use in the diagnosis of gonorrhoea - Google Patents

Antigenically active protein and its use in the diagnosis of gonorrhoea

Info

Publication number
GB2172704B
GB2172704B GB08606293A GB8606293A GB2172704B GB 2172704 B GB2172704 B GB 2172704B GB 08606293 A GB08606293 A GB 08606293A GB 8606293 A GB8606293 A GB 8606293A GB 2172704 B GB2172704 B GB 2172704B
Authority
GB
United Kingdom
Prior art keywords
gonorrhoea
diagnosis
active protein
antigenically active
antigenically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08606293A
Other versions
GB2172704A (en
GB8606293D0 (en
Inventor
Nicholas John Parsons
Harry Smith
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Research Development Corp UK
Original Assignee
National Research Development Corp UK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858506970A external-priority patent/GB8506970D0/en
Application filed by National Research Development Corp UK filed Critical National Research Development Corp UK
Publication of GB8606293D0 publication Critical patent/GB8606293D0/en
Publication of GB2172704A publication Critical patent/GB2172704A/en
Application granted granted Critical
Publication of GB2172704B publication Critical patent/GB2172704B/en
Expired legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/095Neisseria
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1217Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Neisseriaceae (F)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/77Internalization into the cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GB08606293A 1985-03-18 1986-03-13 Antigenically active protein and its use in the diagnosis of gonorrhoea Expired GB2172704B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858506970A GB8506970D0 (en) 1985-03-18 1985-03-18 Antigenically active protein
US78972585A 1985-10-21 1985-10-21

Publications (3)

Publication Number Publication Date
GB8606293D0 GB8606293D0 (en) 1986-04-16
GB2172704A GB2172704A (en) 1986-09-24
GB2172704B true GB2172704B (en) 1988-07-13

Family

ID=26288992

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08606293A Expired GB2172704B (en) 1985-03-18 1986-03-13 Antigenically active protein and its use in the diagnosis of gonorrhoea

Country Status (3)

Country Link
EP (1) EP0216841A1 (en)
GB (1) GB2172704B (en)
WO (1) WO1986005592A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0348144B1 (en) * 1988-06-22 1996-01-10 Hygeia Sciences, Inc. Method for treating mucus-containing immunoassay samples
GB8921227D0 (en) * 1989-09-20 1989-11-08 Wellcome Found Antibodies and proteins
WO2009108307A2 (en) * 2008-02-26 2009-09-03 University Of Massachusetts Diagnostic uses of anti-h8 monoclonal antibodies

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4178359A (en) * 1976-10-12 1979-12-11 Hoffmann-La Roche Inc. Immunoassay method
NL7804410A (en) * 1977-05-09 1978-11-13 Merck & Co Inc METHOD FOR DETERMINING THE TITER OF AN ANTI-BODY AGAINST GRAMNEGATIVE BACTERIA, OR FOR DETERMINING THE IDENTITY OF A GRAMNEGATIVE BACTERY AND TEST KIT FOR PERFORMING THE METHOD. 250478 METHOD FOR DETERMINING THE TITER OF AN ANTI-BODY AGAINST GRAM-NEGATIVE BACTERIA, RESPECTIVE- GATIVE BACTERY AND TEST KIT FOR PERFORMANCE
GB2018796B (en) * 1978-03-29 1982-07-28 Ici Ltd Emulsifiable compositions
US4220450A (en) * 1978-04-05 1980-09-02 Syva Company Chemically induced fluorescence immunoassay
US4241045A (en) * 1978-05-15 1980-12-23 Research Corporation Purified antigen to test for Neisseria gonorrheae antibodies
US4332890A (en) * 1978-05-15 1982-06-01 Abbott Laboratories Detection of neisseria gonorrhoeae
US4288557A (en) * 1978-10-12 1981-09-08 Merck & Co., Inc. Antigenic complex from N. gonorrhoeae
US4299916A (en) * 1979-12-26 1981-11-10 Syva Company Preferential signal production on a surface in immunoassays
US4366241A (en) * 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
WO1983003354A1 (en) * 1982-03-30 1983-10-13 Us Army Neisseria gonorrhoeae vaccine

Also Published As

Publication number Publication date
WO1986005592A1 (en) 1986-09-25
GB2172704A (en) 1986-09-24
EP0216841A1 (en) 1987-04-08
GB8606293D0 (en) 1986-04-16

Similar Documents

Publication Publication Date Title
GB2174037B (en) Absorbent unit and diaper comprising the unit
ZA874574B (en) Encapsulated active ingredients and use in ingested products
IL113844A (en) N-(alpha-ETHYLBENZYL)-3-HYDROXY-2-PHENYLQUINOLINE-4-CARBOXAMIDE AND ITS USE IN THE PREPARATION OF MEDICAMENTS
EP0204597A3 (en) Use of alfuzosine in the treatment of urinary affections
AU6399786A (en) Polypeptides used in the diagnosis and therapy of AIDS
DE3566886D1 (en) N-(aminoalkylphenyl)sulfonamides their preparation and therapeutic use
EP0114777A3 (en) Expression vehicles and their use in the preparation of a protein having human alpha-antitrypsin activity
ZA876435B (en) The use of scr's in extended retarding
ZM4886A1 (en) Medicaments and their use
IL79163A0 (en) 1,8-bridged 4-quinolone-3-carboxylic acids,their preparation,medicaments containing them and their use for the preparation of medicaments
GB2203645B (en) Improvements in the treatment of hair
GB2172704B (en) Antigenically active protein and its use in the diagnosis of gonorrhoea
GB2157684B (en) Triazolopyrimidines their preparation and use in medicine
PH22540A (en) Salts of 3-acylaminobenzisothiazole-s,s-dioxides,the preparation thereof and the use thereof in pest control
PH23435A (en) Benzamide and application thereof in the therapeutic field
EG18799A (en) Phenylthioureas, phenylisothioureas and phenylcarbodumides their preparation and use in the control of pests
DE3662058D1 (en) Leather-treating agent and its use
EP0212783A3 (en) Use of imidazolinylaminoisoindolines and related compounds in the treatment of hyperglycaemia
PL263367A1 (en) Specific for hair and body care
IL84817A (en) N-phenyl-n-carboxythioureas and their use in the control of pests
NZ221570A (en) 3-alkyl-4-heptenoic or -heptanoic acids and use as intermediates in the preparation of n-(s-3-alkylheptanoyl)-d-gamma-glutamyl-glycyl-d-alanine
ZA869678B (en) Use of oligopeptides in the treatment of viral infections
ZA919604B (en) The use of carbozones as novel active ingredients in medicaments
ZA864445B (en) Salts of 3-acylaminobenzisothiazole-s,s-dioxides,the preparation thereof and the use thereof in pest control
IE870675L (en) Noninvasive determination of peripheral outflow and flow¹disturbances in the extremities of human beings

Legal Events

Date Code Title Description
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930313